Litcius/Paper detail

TGF-β in Renal Fibrosis: Triumphs and Challenges

Yue-Yu Gu, Xusheng Liu, Xiao‐Ru Huang, Xueqing Yu, Hui Y. Lan

2020Future Medicinal Chemistry59 citationsDOI

Abstract

Renal fibrosis is a hallmark of chronic kidney disease. Although considerable achievements in the pathogenesis of renal fibrosis have been made, the underlying mechanisms of renal fibrosis remain largely to be explored. Now we have reached the consensus that TGF-β is a master regulator of renal fibrosis. Indeed, TGF-β regulates renal fibrosis via both canonical and noncanonical TGF-β signaling. Moreover, ongoing renal inflammation promotes fibrosis as inflammatory cells such as macrophages, conventional T cells and mucosal-associated invariant T cells may directly or indirectly contribute to renal fibrosis, which is also tightly regulated by TGF-β. However, anti-TGF-β treatment for renal fibrosis remains ineffective and nonspecific. Thus, research into mechanisms and treatment of renal fibrosis remains highly challenging.

Topics & Concepts

FibrosisPathogenesisMedicineKidneyInflammationTransforming growth factorKidney diseaseCancer researchImmunologyPathologyInternal medicineChronic Kidney Disease and DiabetesRenal cell carcinoma treatmentRenal Diseases and Glomerulopathies